Wall Street analysts forecast that U.S. Physical Therapy, Inc. (NYSE:USPH) will post sales of $106.49 million for the current fiscal quarter, according to Zacks. Two analysts have issued estimates for U.S. Physical Therapy’s earnings. The lowest sales estimate is $102.07 million and the highest is $110.91 million. U.S. Physical Therapy posted sales of $90.86 million during the same quarter last year, which would indicate a positive year-over-year growth rate of 17.2%. The company is scheduled to report its next quarterly earnings report on Wednesday, June 6th.

On average, analysts expect that U.S. Physical Therapy will report full-year sales of $106.49 million for the current financial year, with estimates ranging from $406.92 million to $415.75 million. For the next fiscal year, analysts anticipate that the business will report sales of $451.17 million per share, with estimates ranging from $440.26 million to $462.09 million. Zacks Investment Research’s sales averages are a mean average based on a survey of analysts that cover U.S. Physical Therapy.

U.S. Physical Therapy (NYSE:USPH) last released its quarterly earnings data on Thursday, November 2nd. The company reported $0.48 EPS for the quarter, missing analysts’ consensus estimates of $0.52 by ($0.04). The business had revenue of $103.03 million during the quarter, compared to analyst estimates of $102.69 million. U.S. Physical Therapy had a return on equity of 13.37% and a net margin of 5.29%.

A number of research firms have issued reports on USPH. Cantor Fitzgerald reiterated a “buy” rating and issued a $72.00 target price on shares of U.S. Physical Therapy in a research note on Tuesday, September 26th. Sidoti upgraded U.S. Physical Therapy from a “neutral” rating to a “buy” rating and raised their target price for the company from $62.00 to $74.00 in a research note on Friday, September 8th. Zacks Investment Research cut U.S. Physical Therapy from a “buy” rating to a “hold” rating in a research note on Saturday, September 2nd. BidaskClub upgraded U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research note on Wednesday, October 25th. Finally, Barrington Research cut U.S. Physical Therapy from an “outperform” rating to a “market perform” rating in a research note on Friday, November 3rd. One investment analyst has rated the stock with a sell rating, three have given a hold rating and two have issued a buy rating to the stock. The company has a consensus rating of “Hold” and a consensus target price of $69.00.

U.S. Physical Therapy (NYSE:USPH) remained flat at $$70.65 during trading on Friday. The company’s stock had a trading volume of 24,403 shares, compared to its average volume of 57,333. The stock has a market cap of $899.55, a price-to-earnings ratio of 34.54, a P/E/G ratio of 3.07 and a beta of 1.08. The company has a debt-to-equity ratio of 0.30, a current ratio of 2.04 and a quick ratio of 2.04. U.S. Physical Therapy has a twelve month low of $56.50 and a twelve month high of $78.00.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 8th. Investors of record on Friday, November 17th will be paid a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a dividend yield of 1.13%. The ex-dividend date is Thursday, November 16th. U.S. Physical Therapy’s dividend payout ratio is currently 48.19%.

In related news, CEO Christopher J. Reading sold 15,000 shares of U.S. Physical Therapy stock in a transaction dated Wednesday, November 8th. The stock was sold at an average price of $66.52, for a total transaction of $997,800.00. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CFO Lawrance W. Mcafee sold 800 shares of U.S. Physical Therapy stock in a transaction dated Friday, November 3rd. The stock was sold at an average price of $69.21, for a total value of $55,368.00. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 23,000 shares of company stock worth $1,535,652. Company insiders own 3.10% of the company’s stock.

A number of large investors have recently added to or reduced their stakes in the stock. Wells Fargo & Company MN increased its stake in U.S. Physical Therapy by 2.1% in the 2nd quarter. Wells Fargo & Company MN now owns 45,372 shares of the company’s stock worth $2,740,000 after purchasing an additional 914 shares in the last quarter. Great Lakes Advisors LLC increased its stake in U.S. Physical Therapy by 22.4% in the 2nd quarter. Great Lakes Advisors LLC now owns 26,640 shares of the company’s stock worth $1,609,000 after purchasing an additional 4,874 shares in the last quarter. Aberdeen Asset Management PLC UK increased its stake in U.S. Physical Therapy by 13.4% in the 2nd quarter. Aberdeen Asset Management PLC UK now owns 705,007 shares of the company’s stock worth $42,582,000 after purchasing an additional 83,253 shares in the last quarter. Marshall Wace North America L.P. increased its stake in U.S. Physical Therapy by 450.3% in the 2nd quarter. Marshall Wace North America L.P. now owns 19,122 shares of the company’s stock worth $1,147,000 after purchasing an additional 15,647 shares in the last quarter. Finally, Vanguard Group Inc. increased its stake in U.S. Physical Therapy by 6.5% in the 1st quarter. Vanguard Group Inc. now owns 641,533 shares of the company’s stock worth $41,892,000 after purchasing an additional 39,290 shares in the last quarter. 99.75% of the stock is currently owned by hedge funds and other institutional investors.

COPYRIGHT VIOLATION WARNING: This news story was first published by TheOlympiaReport and is the property of of TheOlympiaReport. If you are viewing this news story on another publication, it was stolen and reposted in violation of United States & international copyright and trademark law. The legal version of this news story can be accessed at https://theolympiareport.com/2017/12/06/u-s-physical-therapy-inc-usph-expected-to-post-quarterly-sales-of-106-49-million.html.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care, and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries.

Get a free copy of the Zacks research report on U.S. Physical Therapy (USPH)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for U.S. Physical Therapy Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.